Loading insider details...
Beta
Latest Form 4 (Aug 3, 2026): Purchase of 286,205 LBRX shares, $10.00M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | LB PHARMACEUTICALS INC (LBRX) | Purchase | 286,205 | $10.00M |
| Feb 11, 2026 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Tender of Shares | 15,726,349 | n/a |
| Feb 10, 2026 | LB PHARMACEUTICALS INC (LBRX) | Purchase | 378,444 | $8.01M |
| Sep 16, 2025 | LB PHARMACEUTICALS INC (LBRX) | Conversion | 686,138 | n/a |
| Aug 23, 2025 | DYNAVAX TECHNOLOGIES CORP (DVAX) | Sale | 1,094,994 | $12.08M |
| May 13, 2024 | NEKTAR THERAPEUTICS (NKTR) | Sale | 56,000 | $99.6K |